Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Other Operating Expenses (2017 - 2025)

Tandem Diabetes Care's Other Operating Expenses history spans 8 years, with the latest figure at $75.2 million for Q1 2025.

  • For Q1 2025, Other Operating Expenses changed N/A year-over-year to $75.2 million; the TTM value through Dec 2025 reached $75.2 million, up 7521800.0%, while the annual FY2025 figure was $75.2 million, N/A changed from the prior year.
  • Other Operating Expenses reached $75.2 million in Q1 2025 per TNDM's latest filing, up from -$1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $78.8 million in Q1 2023 to a low of -$1000.0 in Q4 2024.
  • Average Other Operating Expenses over 4 years is $37.0 million, with a median of $31.0 million recorded in 2022.